🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Florida › Orlando

Uji klinis Kanker (semua jenis) di Orlando, FL

24 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Registry Study for Radiation Therapy Outcomes

Menerima pesertaStudi observasional
  • Orlando Health Cancer Institute, Orlando
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT01255748

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • GSK Investigational Site, Reunion · 23 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07277270

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Menerima pesertaFase 3
  • Advent Health, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07195591

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Menerima pesertaFase 3
  • Orlando Health Cancer Institute /ID# 280418, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07365241

Visugromab in Cachexia International Trial

Menerima pesertaFase 2/3
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07112196

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Orlando Health Cancer Institute, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Menerima pesertaFase 2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07252739

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Menerima pesertaFase 3
  • Advent Health - Orlando, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • AdventHealth Orlando, Orlando
  • Arnold Palmer Hospital for Children, Orlando
  • Nemours Children's Hospital, Orlando
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • AdventHealth Celebration, Celebration · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Menerima pesertaFase 3
  • Orlando Health Cancer Institute, Orlando
  • Health Central, Ocoee · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Menerima pesertaFase 1/2
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT05533697

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Menerima pesertaFase 1
  • GSK Investigational Site, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06431594

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Menerima pesertaFase 1/2
  • Orlando Health Cancer Institute, Orlando
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Menerima pesertaFase 1
  • Research Site, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06835569

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Menerima pesertaFase 2
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06463665

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Menerima peserta
  • Orlando Health, Orlando
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT05838638

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • AdventHealth Cancer Institute, Celebration · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT05948865

GEMINI-NSCLC: NSCLC Biomarker Study

Menerima pesertaStudi observasional
  • Clermont Oncology Center, Clermont · 24 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Arnold Palmer Hospital for Children, Orlando
Semua usia · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT04715178

Caris Biorepository Research Protocol

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Advent Health, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT01499394

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Menerima pesertaStudi observasional
  • AdventHealth Cancer Institute, Orlando
Usia 18 ke atas · Wanita · Diperbarui 29 Jan 2025 · NCT04957511

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Menerima pesertaStudi observasional
  • University of Central Florida, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT06148298

Uji klinis Kanker (semua jenis) di kota lain

Studi lain di Orlando

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.